Jan Pruim

2.4k total citations · 1 hit paper
19 papers, 1.7k citations indexed

About

Jan Pruim is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Jan Pruim has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Jan Pruim's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Medical Imaging Techniques and Applications (6 papers). Jan Pruim is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Medical Imaging Techniques and Applications (6 papers). Jan Pruim collaborates with scholars based in Netherlands, South Africa and United States. Jan Pruim's co-authors include Willem Vaalburg, Igle J. de Jong, Gerard H. Koëter, J. J. Meuzelaar, Remge M. Pieterman, V. Fidler, Eduard L. Mooyaart, John W.G. van Putten, Harry J.M. Groen and Philip H. Elsinga and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Cardiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jan Pruim

19 papers receiving 1.7k citations

Hit Papers

Preoperative Staging of Non–Small-Cell Lung Cancer with P... 2000 2026 2008 2017 2000 250 500 750

Peers

Jan Pruim
Houke M. Klomp Netherlands
Jan Pruim
Citations per year, relative to Jan Pruim Jan Pruim (= 1×) peers Houke M. Klomp

Countries citing papers authored by Jan Pruim

Since Specialization
Citations

This map shows the geographic impact of Jan Pruim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Pruim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Pruim more than expected).

Fields of papers citing papers by Jan Pruim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Pruim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Pruim. The network helps show where Jan Pruim may publish in the future.

Co-authorship network of co-authors of Jan Pruim

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Pruim. A scholar is included among the top collaborators of Jan Pruim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Pruim. Jan Pruim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wondergem, Maurits, Friso M. van der Zant, Remco J.J. Knol, et al.. (2017). 18F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution. Journal of Nuclear Medicine. 58(11). 1797–1804. 45 indexed citations
2.
Wondergem, Maurits, Friso M. van der Zant, Remco J.J. Knol, et al.. (2017). 99mTc-HDP bone scintigraphy and 18F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer. World Journal of Urology. 36(1). 27–34. 26 indexed citations
3.
Wondergem, Maurits, Friso M. van der Zant, Remco J.J. Knol, Jan Pruim, & Igle J. de Jong. (2016). Impact of fasting on 18F-fluorocholine gastrointestinal uptake and detection of lymph node metastases in patients with prostate cancer. EJNMMI Research. 6(1). 2–2. 4 indexed citations
4.
Breeuwsma, A.J., et al.. (2012). Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer. World Journal of Urology. 31(2). 319–323. 42 indexed citations
5.
Plattel, Wouter J., et al.. (2011). PROGNOSTIC VALUE OF PLASMA CCL17/TARC IN COMPARISON TO FDG-PET IMAGING IN CLASSICAL HODGKIN LYMPHOMA. Data Archiving and Networked Services (DANS). 56(5). 879–879. 1 indexed citations
6.
Wiegman, Erwin M., et al.. (2010). PET/CT and radiotherapy in prostate cancer.. PubMed. 54(5). 543–52. 5 indexed citations
7.
Breeuwsma, A.J., Jan Pruim, A.C.M. van den Bergh, et al.. (2009). Detection of Local, Regional, and Distant Recurrence in Patients With PSA Relapse After External-Beam Radiotherapy Using 11C-Choline Positron Emission Tomography. International Journal of Radiation Oncology*Biology*Physics. 77(1). 160–164. 73 indexed citations
8.
Jong, Igle J. de, A.J. Breeuwsma, & Jan Pruim. (2007). Positron Emission Tomography in Urology. University of Groningen research database (University of Groningen / Centre for Information Technology). 5(3). 93–104. 1 indexed citations
9.
Breeuwsma, A.J., Jan Pruim, Albert J.H. Suurmeijer, et al.. (2005). In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 32(6). 668–673. 86 indexed citations
10.
Imhoff, Gustaaf van, et al.. (2003). Predictive value of early 18F‐fluoro‐deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma. British Journal of Haematology. 123(2). 282–287. 49 indexed citations
11.
Jong, Igle J. de, Jan Pruim, Philip H. Elsinga, Willem Vaalburg, & Han J.A. Mensink. (2003). Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.. PubMed. 44(3). 331–5. 209 indexed citations
12.
Jong, Igle J. de, et al.. (2002). Visualisation of bladder cancer using 11C-choline PET: first clinical experience. European Journal of Nuclear Medicine and Molecular Imaging. 29(10). 1283–1288. 84 indexed citations
13.
Jager, Pieter L., D. A. Piers, Jan Pruim, et al.. (2002). Better Yield of 18 Fluorodeoxyglucose-Positron Emission Tomography in Patients with Metastatic Differentiated Thyroid Carcinoma during Thyrotropin Stimulation. Thyroid. 12(5). 381–387. 62 indexed citations
14.
Pieterman, Remge M., John W.G. van Putten, J. J. Meuzelaar, et al.. (2000). Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography. New England Journal of Medicine. 343(4). 254–261. 864 indexed citations breakdown →
15.
Hautvast, Raymond W.M., Paul K. Blanksma, Mike J.L. DeJongste, et al.. (1996). Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris. The American Journal of Cardiology. 77(7). 462–467. 115 indexed citations
16.
Nieweg, Omgo E., Jan Pruim, Harald Hoekstra, et al.. (1994). Positron emission tomography with fluorine-18-fluorodeoxyglucose for the evaluation of therapeutic isolated regional limb perfusion in a patient with soft-tissue sarcoma.. PubMed. 35(1). 90–2. 17 indexed citations
17.
Jansen, H.W.B., Jan Pruim, Antonius Willemsen, et al.. (1994). DETECTION OF NEURONAL DAMAGE IN DEGENERATIVE BRAIN DISEASE WITH COBALT-55 AND POSITRON EMISSION TOMOGRAPHY. Data Archiving and Networked Services (DANS). 35(5). 1 indexed citations
18.
Pruim, Jan, et al.. (1993). Selection criteria for liver donation: a review. Transplant International. 6(4). 226–235. 31 indexed citations
19.
Pruim, Jan, et al.. (1989). Hepatic artery thrombosis after orthotopic liver transplantation--a fatal complication or an asymptomatic event.. PubMed. 21(1 Pt 2). 2462–2462. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026